Markets:

Overview

News

Currencies

International

Treasuries

Freshpet, Inc. - Common Stock (NQ:FRPT)

63.68 +1.63 (+2.63%)

Streaming Delayed Price Updated: 12:09 PM EST, Dec 8, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Freshpet, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Is Freshpet Ready For A Fresh Rally?

February 27, 2023

Freshpet is on track to sustained growth and profitability that could put the stock in a reversal. Analysts and institutions are buying, too,

Via MarketBeat

Topics Economy

Analysts and Executives Converge February 2nd at the 30th Annual Emerald Groundhog Day Investment Forum

January 26, 2023

From Emerald Asset Management PA, LLC

Via Business Wire

Freshpet's Visibility Of Margin Improvement Makes This Analyst Remain Bullish On The Stock ↗

January 11, 2023

Via Benzinga

Chewy Stock: Bull vs. Bear ↗

December 21, 2022

Is the pet products retailer a buy? See what the bulls and bears have to say.

Via The Motley Fool

Analyst Ratings for Freshpet ↗

December 07, 2022

Via Benzinga

What 13 Analyst Ratings Have To Say About Freshpet ↗

November 03, 2022

Within the last quarter, Freshpet (NASDAQ:FRPT) has observed the following analyst ratings:

Via Benzinga

Expert Ratings for Freshpet ↗

November 03, 2022

Within the last quarter, Freshpet (NASDAQ:FRPT) has observed the following analyst ratings:

Via Benzinga

Freshpet (FRPT) Q3 2022 Earnings Call Transcript ↗

November 01, 2022

FRPT earnings call for the period ending September 30, 2022.

Via The Motley Fool

Earnings Scheduled For February 27, 2023 ↗

February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Via Benzinga

Earnings Preview For Freshpet ↗

February 24, 2023

Via Benzinga

What 10 Analyst Ratings Have To Say About Freshpet ↗

September 08, 2022

Analysts have provided the following ratings for Freshpet (NASDAQ:FRPT) within the last quarter:

Via Benzinga

Lyft Price Target Cut By 56%; Plus Piper Sandler Sees $61 For Five9 ↗

November 08, 2022

Evercore ISI Group cut the price target on Lyft, Inc. (NASDAQ: LYFT) from $41 to $18. Lyft shares fell 17.1% to $11.72 on Tuesday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022 ↗

November 03, 2022

Upgrades

Via Benzinga

Freshpet: A Fresh Time To Buy Into This Growth Story?

November 02, 2022

Freshpet is pulling back after a weaker-than-expected report but there are signs the stock is bottoming and expected improvements in the margin is coming.

Via MarketBeat

Topics Economy

Freshpet Finance Chief Steps Down; Co. Reaffirms FY22 Outlook ↗

September 07, 2022

Via Benzinga

Jim Cramer Says Freshpet Is 'Too Expensive,' This Stock Has 'A Better Pet Food Division' ↗

October 19, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Freshpet, Inc. (NASDAQ: FRPT) is "too expensive." He said General Mills, Inc.

Via Benzinga

Short Interest Sector Focus: Consumer Defensive Sector ↗

October 12, 2022

As of the close of business on Tuesday, 10/11, we captured the Top 10 Highest Short Interest % stocks within the Consumer Defensive Sector. The average short interest for stocks within the Consumer...

Via Benzinga

Expert Ratings for Freshpet ↗

September 30, 2022

Over the past 3 months, 11 analysts have published their opinion on Freshpet (NASDAQ:FRPT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Where Freshpet Stands With Analysts ↗

September 30, 2022

Over the past 3 months, 11 analysts have published their opinion on Freshpet (NASDAQ:FRPT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022 ↗

September 30, 2022

Upgrades

Via Benzinga

Will Activist Investors Change the Game for Freshpet (FRPT) Stock? ↗

September 23, 2022

Freshpet (FRPT) stock is rallying on Friday as traders look to news of an activist stake in the company as a potential positive.

Via InvestorPlace

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗

September 23, 2022

Gainers

Via Benzinga

7 Kim Kardashian Stocks to Buy ↗

September 14, 2022

These Kim Kardashian Stocks to Buy are what's Kimmie's new equity firm is all about. There's no reason she won't succeed here as well.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022 ↗

September 08, 2022

Via Benzinga

Short Interest Sector Focus: Consumer Defensive Sector ↗

August 25, 2022

As of the close of business on Wednesday, 8/25, we captured the Top 10 Highest Short Interest % stocks within the Consumer Defensive Sector. The average short interest for stocks within the Consumer...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2022 ↗

August 18, 2022

Via Benzinga

Your Pet Or Car? When Times Got Rough, Consumers Made A Tough Choice This Summer ↗

August 15, 2022

Freshpet Inc’s (NASDAQ: FRPT) second-quarter earnings report offered great insight into the current macroeconomic trends currently affecting the pockets of Americans.

Via Benzinga

Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday ↗

August 10, 2022

U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗

August 09, 2022

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.